(111) experimentally tested four anti-CD147 antibodies in HCC, and found that while 1B 3 and 3B 3 effectively inhibited MMP-2 secretion and cell invasion, HAb 18 Gedomab 1 and HAb18 Gedomab 2 exhibited opposite effects. Here, BSG is linked to hepatocellular carcinoma.